CELG

Recent Articles

Is the SPDR S&P Biotech (ETF) (XBI) Done Running?

Biotech stocks are booming, but resistance looms close. Time to take profits on the SPDR S&P Biotech (ETF) XBI calls, but also consider reloading. More 

5 Biotech Stocks That Are Roaring Back to Life

These biotech stocks are making their way past recent lows based on a potential pause in focus and action by Trump. More 

3 Biotech Trades to Diversify Your Portfolio

There’s always a bull market somewhere. At times, there are bulls and bears in the same sector, as is the case with these biotech stocks. More 

Celgene Corporation (CELG) Stock’s Range Is Tight — Time to Profit

The CELG stock price is in the middle of its recent range. With no impending risks, I sell downside risk to generate income from Celgene. More 

5 Top Stocks to Buy in June

These five stocks to buy have a history of outperformance in June, with some of them kick-starting longer-term rallies. More 

7 S&P 500 Stocks That Will Drop by Double Digits

Will the market keep rallying or crash from its highs? Doesn't matter. These 7 S&P 500 stocks are on the verge of collapse either way. More 

iShares Nasdaq Biotechnology Index (ETF) (IBB): The Quick Guide to IBB

The $8 billion-plus iShares Nasdaq Biotechnology ETF (IBB) has a deep bench relative to other biotechnology funds. Is IBB right for you? More